MedicalCountermeaures.gov

Day 1 - Monday, December 10, 2012

	Nicole Lurie, MD: Keynote Address - MCM State of Affairs
	Carol D. Linden, Ph.D.: 2012 HHS PHEMCE Strategy and Implementation Plan
	Michael Kurilla, M.D., Ph.D.: MCM Development and Manufacturing NIH Perspectives
	Gerald R. Kovacs, Ph.D.: BARDA CBRN Medical Countermeasures Portfolio
	Anthony Macaluso, Ph.D.: Chemical Biological Medical Systems
	Luciana Borio, M.D.: Pathways for Medical Countermeasure Development and Use
	Daniel Sosin, MD, MPH, FACP: 2012 PHEMCE Strategy Goal 3
	Richard L Gorman, MD: PHEMCE Partner Efforts in Support of Goal 4 of the 2012 PHEMCE Strategy
	Louise Pitt, Ph.D.: Animal Models and Efficacy Studies
	Judith A. Hewitt, Ph.D.: Animal Model Resources for MCM Development
	Thomas M. Dreier, Ph.D.: BARDA Nonclinical Development Network
	Dr. Robert Johnson: Clinical Resources for Microbiology and Infectious Diseases Research Community
	Jo Ellen Schweinle, MD: BARDA Division of Clinical Studies
	Dr. Alan Liss: FDA's Medical Countermeasures Initiative (MCMi)
	Debra A. Yeskey Pharm.D.: Regulatory and Quality Affairs
	Mike Angelastro: Core Service Support for MCM Advanced Development and Manufacturing
	Rosemarie Aurigemma, Ph.D.: Development of Antimicrobials and Broad-Spectrum Activity: Antibiotics
	Joe Larsen, Ph.D.: Broad Spectrum Antimicrobials (BSA)
	Michael Wathen: Improving Pipeline for the Development of Influenza Antivirals
	Judith Wolfe Laney, Ph.D.: Chemical MCM Development at BARDA
	Ronald G. Manning, Ph.D.: Repurposing of approved products for use against public health threats
	Michael Shaw, M.D.: Influenza Diagnostics Update
	Rodney Wallace: CBRN Diagnostics Overview
	Melanie Choe, Ph.D.: Respiratory Devices for Medical Countermeasures
	Lewis Radonovich, M.D.: An Ideal Environment for Health Care Field Testing
	Jonathan Yewdell, M.D., Ph.D.: Influenza Adrift - Rethinking Influenza Vaccination
	Alan Goldberg: Host Directed Therapeutics and Immunomodulators
	Traci Mondoro: Cellular Therapies for Use in Public Health Emergencies
	Anton Simeonov: The NCATS Pharmaceutical Collection-Potential Use for Rapid Repurposing Against New/Emerging Threats

Day 2 - Tuesday, December 11, 2012

	Welcome: Day 2 - BARDA Industry Day - Washington, DC Contracting for Countermeasures, Introduction
	You Are Here Map (Part 1)
	Walkthrough: Requirements Document Example
	Cameron Hernandez: Market Research and Getting Started
	Walkthrough: Market Research Examples
	Dr. Adam Clark: TechWatch
	Susan Cortes - Shrank: Broad Agency Announcements (BAA), Request for Proposals (RFP)and Their Differences
	Walkthrough: Solicitation Outline Examples
	Walkthrough: Recap 1
	You Are Here Map (Part 2)
	Malda Brown: Small Business 101
	Tasha McMillian: White Paper Review Process & Invite / Do-Not-Invite Letters
	Eric Steinberg: Walkthrough: Invite / Do-Not-Invite Letter Examples
	Eric Steinberg: Contract Types
	Contract Type Matrix
	Walkthrough: Contract Table of Contents Example
	Jolinda Summers: Business Tool Kit
	Jason Vettickal: Earned Value Management
	Brooke Bernold: Mock T.E.P.
	Walkthrough: Recap 2
	You Are Here Map (Part 3)
	Matthew Rose: Introduction to Negotiations
	Walkthrough: Recap 3
	Francine Hemphill: Debriefing
	Walkthrough: Recap 4
	You Are Here Map (Part 4)
	Susan Cortes-Shrank: Contracting Officer's Authorization (COA)
	Walkthrough: COA Example
	Forest Crumpler: Show Me the Money™: Invoices in Brief
	Invoicing Pitfalls
	Walkthrough: Invoice Example
	Brendan Miller: Contract Modifications
	Jolinda Summers: In Process Reviews (IPR)
	Jolinda Summers: Mock IPR
	Barbara Orlando: Division Of Grants
	Andre Early: Commercial Items
	Walkthrough: Recap 5
	ASPR Acronym